These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Investigating the Function of Cryptic Cytochalasan Cytochrome P450 Monooxygenases Using Combinatorial Biosynthesis. Wang C; Becker K; Pfütze S; Kuhnert E; Stadler M; Cox RJ; Skellam E Org Lett; 2019 Nov; 21(21):8756-8760. PubMed ID: 31644300 [TBL] [Abstract][Full Text] [Related]
46. Characterization of alkylguaiacol-degrading cytochromes P450 for the biocatalytic valorization of lignin. Fetherolf MM; Levy-Booth DJ; Navas LE; Liu J; Grigg JC; Wilson A; Katahira R; Beckham GT; Mohn WW; Eltis LD Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25771-25778. PubMed ID: 32989155 [TBL] [Abstract][Full Text] [Related]
47. Engineering and application of enzymes for lipid modification, an update. Zorn K; Oroz-Guinea I; Brundiek H; Bornscheuer UT Prog Lipid Res; 2016 Jul; 63():153-64. PubMed ID: 27301784 [TBL] [Abstract][Full Text] [Related]
48. Exploiting a C-N Bond Forming Cytochrome P450 Monooxygenase for C-S Bond Formation. Morita I; Mori T; Mitsuhashi T; Hoshino S; Taniguchi Y; Kikuchi T; Nagae K; Nasu N; Fujita M; Ohwada T; Abe I Angew Chem Int Ed Engl; 2020 Mar; 59(10):3988-3993. PubMed ID: 31886618 [TBL] [Abstract][Full Text] [Related]
49. Research advances in cytochrome P450-catalysed pharmaceutical terpenoid biosynthesis in plants. Zheng X; Li P; Lu X J Exp Bot; 2019 Sep; 70(18):4619-4630. PubMed ID: 31037306 [TBL] [Abstract][Full Text] [Related]
50. Oxygen Surrogate Systems for Supporting Human Drug-Metabolizing Cytochrome P450 Enzymes. Strohmaier SJ; De Voss JJ; Jurva U; Andersson S; Gillam EMJ Drug Metab Dispos; 2020 Jun; 48(6):432-437. PubMed ID: 32238418 [TBL] [Abstract][Full Text] [Related]
51. Oxygenating Biocatalysts for Hydroxyl Functionalisation in Drug Discovery and Development. Charlton SN; Hayes MA ChemMedChem; 2022 Jun; 17(12):e202200115. PubMed ID: 35385205 [TBL] [Abstract][Full Text] [Related]
52. Cytochrome P450: taming a wild type enzyme. Jung ST; Lauchli R; Arnold FH Curr Opin Biotechnol; 2011 Dec; 22(6):809-17. PubMed ID: 21411308 [TBL] [Abstract][Full Text] [Related]
53. Development of an improved Amplex Red peroxidation activity assay for screening cytochrome P450 variants and identification of a novel mutant of the thermophilic CYP119. Başlar MS; Sakallı T; Güralp G; Kestevur Doğru E; Haklı E; Surmeli NB J Biol Inorg Chem; 2020 Oct; 25(7):949-962. PubMed ID: 32924072 [TBL] [Abstract][Full Text] [Related]
54. Engineering the third wave of biocatalysis. Bornscheuer UT; Huisman GW; Kazlauskas RJ; Lutz S; Moore JC; Robins K Nature; 2012 May; 485(7397):185-94. PubMed ID: 22575958 [TBL] [Abstract][Full Text] [Related]
56. The molecular basis and enzyme engineering strategies for improvement of coupling efficiency in cytochrome P450s. Meng S; Ji Y; Zhu L; Dhoke GV; Davari MD; Schwaneberg U Biotechnol Adv; 2022 Dec; 61():108051. PubMed ID: 36270499 [TBL] [Abstract][Full Text] [Related]
57. Improved cyclopropanation activity of histidine-ligated cytochrome P450 enables the enantioselective formal synthesis of levomilnacipran. Wang ZJ; Renata H; Peck NE; Farwell CC; Coelho PS; Arnold FH Angew Chem Int Ed Engl; 2014 Jun; 53(26):6810-3. PubMed ID: 24802161 [TBL] [Abstract][Full Text] [Related]
58. Biocatalysis for the synthesis of pharmaceuticals and pharmaceutical intermediates. Sun H; Zhang H; Ang EL; Zhao H Bioorg Med Chem; 2018 Apr; 26(7):1275-1284. PubMed ID: 28709846 [TBL] [Abstract][Full Text] [Related]